| pubmed-article:66652 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:66652 | lifeskim:mentions | umls-concept:C0027794 | lld:lifeskim |
| pubmed-article:66652 | lifeskim:mentions | umls-concept:C0002210 | lld:lifeskim |
| pubmed-article:66652 | lifeskim:mentions | umls-concept:C0033053 | lld:lifeskim |
| pubmed-article:66652 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:66652 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:66652 | pubmed:dateCreated | 1977-5-27 | lld:pubmed |
| pubmed-article:66652 | pubmed:abstractText | Alpha-fetoprotein was measured in 2209 amniotic fluid samples under improved assay conditions. All cases of open neural tube defects had elevated values greater than 5 SD above the mean. The false positive rate based on the 3 SD cutoff is estimated at less than 9.15%. Alpha-fetoprotein assays are recommended for all patients undergoing second trimester amniocentesis, optimally between 14 and 16 weeks' gestation. | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:language | eng | lld:pubmed |
| pubmed-article:66652 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:66652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:66652 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:66652 | pubmed:month | May | lld:pubmed |
| pubmed-article:66652 | pubmed:issn | 0029-7844 | lld:pubmed |
| pubmed-article:66652 | pubmed:author | pubmed-author:MilunskyAA | lld:pubmed |
| pubmed-article:66652 | pubmed:author | pubmed-author:AlpertEE | lld:pubmed |
| pubmed-article:66652 | pubmed:author | pubmed-author:KimballM EME | lld:pubmed |
| pubmed-article:66652 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:66652 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:66652 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:66652 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:66652 | pubmed:pagination | 532-6 | lld:pubmed |
| pubmed-article:66652 | pubmed:dateRevised | 2009-10-26 | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Hu... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Pr... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Br... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Ne... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Sp... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Am... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Ne... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Fe... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Ad... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-al... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Fe... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Ge... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Fa... | lld:pubmed |
| pubmed-article:66652 | pubmed:meshHeading | pubmed-meshheading:66652-Pr... | lld:pubmed |
| pubmed-article:66652 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:66652 | pubmed:articleTitle | Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay. | lld:pubmed |
| pubmed-article:66652 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:66652 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:66652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:66652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:66652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:66652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:66652 | lld:pubmed |
